Effects of ABCB1 rs1045642 polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I–II hypertension

D Sychev, N Shikh, T Morozova, E Grishina… - Pharmacogenomics …, 2018 - Taylor & Francis
… The aim of this study was to determine the impact of ABCB1 (MDR1… we can infer that
amlodipine pharmacokinetics is affected by … Kim et al suggested that haplotype analysis rather …

The importance of polymorphisms of the ABCB1 and CYP3A5 genes in predicting the efficacy and safety of amlodipine in patients with arterial hypertension of 1-2 …

TE Morozova, NV Shikh, DA Sychev… - Consilium …, 2017 - journals.eco-vector.com
… to ABCB1, CYP3A5. Materials and methods. Antihypertensive efficacy and tolerability of
amlodipine was evaluated in 100 patients … on the genotypes of the ABCB1 and CYP3A5 genes. …

CYP3A41G and CYP3A53 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation

Y Huang, G Wen, Y Lu, J Wen, Y Ji… - … Journal of Clinical …, 2017 - search.proquest.com
effect of CYP3A4*1G, CYP3A5*3, and MDR1 C3435T gene polymorphisms on the
pharmacokinetics of amlodipine in hypertensive patientseffect of different genotype and …

[HTML][HTML] Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review

R Johnson, P Dludla, S Mabhida, M Benjeddou… - Heart failure …, 2019 - Springer
… CYP3A5 does not affect the pharmacokinetic variability of amlodipine [22… ABCB1 gene (also
known as multi drug resistance 1; MDR1) … The haplotype analysis data suggested that SNPs …

WAYS AND PROSPECTS OF IMPROVING THE EFFECTIVENESS AND SAFETY OF PHARMACOTHERAPY OF CHRONIC GASTRITIS

GSPD Ochilova - Journal of Pharmaceutical Negative Results, 2022 - pnrjournal.com
… of this protein determines the pharmacokinetics of drugs and, … of polymorphisms C3435T,
G2677T, C1236T of the MDR1 gene … Patients with genotypic affiliation with / T made up a huge …

Efficacy and Safety of Pharmacotherapy of Chronic Gastritis

OG Saidovna, OA Kamilovich - Academia Open, 2022 - acopen.umsida.ac.id
… essential for comprehending drug pharmacokinetics and optimizing … of polymorphisms
C3435T, G2677T, C1236T of the MDR1Patients with genotypic affiliation with / T made up a huge …

[HTML][HTML] The drug transporter ABCB1 c.3435C>T SNP influences artemether–lumefantrine treatment outcome

K Kiaco, AS Rodrigues, V do Rosário, JP Gil, D Lopes - Malaria Journal, 2017 - Springer
… membrane of the hepatocyte, the ABCB1 (MDR1/Pgp) ATP-binding … hypothesized that small
pharmacokinetic differences might … and a capillary blood sample obtained for PCR analysis. …

Pharmacokinetic drug interactions between amlodipine, valsartan, and rosuvastatin in healthy volunteers

SJ Seong, B Ohk, WY Kang, MR Gwon, BK Kim… - Advances in …, 2019 - Springer
… The transporter involved in the efflux of amlodipine is multidrug resistance 1 (MDR1) and …
24 h after dosing, and additional 48- and 72-h visits were made for pharmacokinetic sampling. …

DIFFERENTIATED APPROACH TO THE TREATMENT OF CHRONIC GASTRITIS, TAKING INTO ACCOUNT GENETIC MARKERS

GS Ochilova - EUROPEAN JOURNAL OF MODERN MEDICINE AND …, 2022 - inovatus.es
patients to improve pharmacotherapy with chronic gastritis by the MDR1 gene, which provides
the pharmacokinetics … our results and the data obtained by the standardized test system of …

… coupled to LC-MS/MS for simultaneous determination of amlodipine, olmesartan and hydrochlorothiazide in plasma samples: Application to pharmacokinetic studies

EF Elkady, AA Mandour, FK Algethami… - Microchemical …, 2020 - Elsevier
… Drug-free K 3 EDTA human plasma samples were harvested on-site from healthy volunteers
Similarly the deduced pharmacokinetic parameters of HCT came in close agreement with …